Pilocarpine Ocular Inserts

Overview

Journal Invest Ophthalmol

Specialty Ophthalmology

Date 1976 Dec 1

PMID 992960

Citations 5

Authors

R Bensinger

D H Shin

M A Kass

S M Podos

B Becker

Affiliations

Soon will be listed here.

Abstract

Pilocarpine was administered to a selected group of ocular hypertensive subjects in the form of a synthetic biosoluble matrix inserted into the conjunctival cul-de-sac. Satisfactory lowering of the intraocular pressure resulted, with a minimum of subject intolerance. The decreased pressure response was significant in some cases for greater than 24 hours. Drug delivery by soluble inserts offers promise as a convenient and effective mode of therapy.

Citing Articles

Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma.

Albarqi H, Garg A, Ahmad M, Alqahtani A, Walbi I, Ahmad J Pharmaceutics. 2023; 15(2).

PMID: 36840002 PMC: 9963436. DOI: 10.3390/pharmaceutics15020681.

Promising therapeutic drug delivery systems for glaucoma: a comprehensive review.

Singh R, Ichhpujani P, Thakur S, Jindal S Ther Adv Ophthalmol. 2020; 12:2515841420905740.

PMID: 32206746 PMC: 7074511. DOI: 10.1177/2515841420905740.

Ocular Disposition of ∆-Tetrahydrocannabinol from Various Topical Ophthalmic Formulations.

Punyamurthula N, Adelli G, Gul W, Repka M, ElSohly M, Majumdar S AAPS PharmSciTech. 2016; 18(6):1936-1945.

PMID: 27905004 PMC: 5629008. DOI: 10.1208/s12249-016-0672-2.

Biodegradable in situ gelling delivery systems containing pilocarpine as new antiglaucoma formulations: effect of a mercaptoacetic acid/N-isopropylacrylamide molar ratio.

Lai J Drug Des Devel Ther. 2013; 7:1273-85.

PMID: 24187486 PMC: 3810330. DOI: 10.2147/DDDT.S53759.

Prolonged pulse-entry of pilocarpine with a soluble drug insert.

Salminen L, Urtti A, Kujari H, Juslin M Graefes Arch Clin Exp Ophthalmol. 1983; 221(2):96-9.

PMID: 6654048 DOI: 10.1007/BF02133815.